iNtRON Biotechnology, Inc. develops biopharmaceuticals for the prevention and treatment of human diseases worldwide. It develops bacteriophage and endoricin drugs. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea.
Stock data | 2024 | Change |
---|---|---|
Price | $4.57 | N/A |
Market Cap | $151.62M | N/A |
Shares Outstanding | 33.19M | N/A |
Employees | 81.00 | N/A |